Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VOLITIONRX LTDVNRX · Entity 8241 | 10% owner | January 02, 2024 | January 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VOLITIONRX LTD
Report date January 02, 2024 · Filed January 03, 2024
Jointly reported with Hever Investments Ltd
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| VOLITIONRX LTDSEC Table I · non-derivative | IndirectBy Hever Investments Limited | 298,419 |
Reported balance
After 2024-01-02 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-01-02 · Sale · Disposed 20,000 · Balance 298,419 |
| VOLITIONRX LTDSEC Table I · non-derivative | IndirectBy Cotterford Company Limited | 11,706,913 |
Reported balance
Holding disclosure · report date 2024-01-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 11,706,913 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2024 Filed Jan 3, 2024 15:41 UTC | VOLITIONRX LTD VNRX · Entity 8241 | SaleVOLITIONRX LTD | 20,000 | $0.90 | $18,000.00 |
DisclosureSEC source: 0001762625-24-000001 · primary_doc.xml · nonDerivative · entry 1 Eight Corp Ltd · CIK 0001762625 · 10% owner Hever Investments Ltd · CIK 0001761448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Hever Investments Limited Disclosed balance after: 298,419 Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 15:31 UTC | VOLITIONRX LTD VNRX · Entity 8241 | SaleCommon Stock | 20,000 | $0.75 | $15,000.00 |
DisclosureSEC source: 0001762625-23-000001 · primary_doc.xml · nonDerivative · entry 1 Eight Corp Ltd · CIK 0001762625 · 10% owner Hever Investments Ltd · CIK 0001761448 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Hever Investments Limited Disclosed balance after: 318,419 Read SEC document |
| October 01, 2019 Filed Oct 18, 2019 20:28 UTC | VOLITIONRX LTD VNRX · Entity 8241 | PurchaseCommon Stock | 50,000 | $5.69 | $284,570.00 |
DisclosureSEC source: 0001078782-19-000778 · primary_doc.xml · nonDerivative · entry 1 Eight Corp Ltd · CIK 0001762625 · 10% owner Cotterford Co Ltd · CIK 0001761462 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Cotterford Company Limited Disclosed balance after: 11,706,913 F1 · kind: The reporting person's purchase of Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 46,238 shares, with the reporting person's sale of 46,238 shares of Issuer's common stock at a price of $6.0295 per share on September 27, 2019. The reporting person has paid to Issuer $15,633.07, representing the full amount of the profit realized in connection with the short-swing transaction. F2 · ownership.nature: The securities are owned by Cotterford Company Limited ("Cotterford"). Eight Corporation Limited ("ECL") serves as the sole director of Cotterford, holds dispositive and voting control over the securities of the issuer owned by Cotterford, and may be deemed to have indirect beneficial ownership of the securities of the issuer held by Cotterford. ECL owns no securities of the issuer directly and disclaims beneficial ownership of such securities owned by Cotterford, except to the extent of its pecuniary interest therein. Read SEC document |
| September 26, 2019 Filed Sep 30, 2019 20:13 UTC | VOLITIONRX LTD VNRX · Entity 8241 | SaleCommon Stock | 46,238 | $6.03 | $278,792.02 |
DisclosureSEC source: 0001078782-19-000742 · primary_doc.xml · nonDerivative · entry 1 Eight Corp Ltd · CIK 0001762625 · 10% owner Cotterford Co Ltd · CIK 0001761462 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Cotterford Company Limited Disclosed balance after: 11,656,913 F1 · ownership.nature: The securities are owned by Cotterford Company Limited ("Cotterford"). Eight Corporation Limited ("ECL") serves as the sole director of Cotterford, holds dispositive and voting control over the securities of the issuer owned by Cotterford, and may be deemed to have indirect beneficial ownership of the securities of the issuer held by Cotterford. ECL owns no securities of the issuer directly and disclaims beneficial ownership of such securities owned by Cotterford, except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.